Kakinuma Toshiyuki, Kakinuma Kaoru, Okamoto Rora, Yanagida Kaoru, Ohwada Michitaka, Takeshima Nobuhiro
Department of Obstetrics and Gynecology, International University of Health and Welfare Hospital, Tochigi 329-2763, Japan.
World J Clin Cases. 2024 Feb 16;12(5):980-987. doi: 10.12998/wjcc.v12.i5.980.
Microwave endometrial ablation (MEA) is a minimally invasive treatment method for heavy menstrual bleeding. However, additional treatment is often required after recurrence of uterine myomas treated with MEA. Additionally, because this treatment ablates the endometrium, it is not indicated for patients planning to become pregnant. To overcome these issues, we devised a method for ultrasound-guided microwave ablation of uterine myoma feeder vessels. We report three patients successfully treated for heavy menstrual bleeding, secondary to uterine myoma, using our novel method.
All patients had a favorable postoperative course, were discharged within 4 h, and experienced no complications. Further, no postoperative recurrence of heavy menstrual bleeding was noted. Our method also reduced the myoma's maximum diameter.
This method does not ablate the endometrium, suggesting its potential application in patients planning to become pregnant.
微波子宫内膜消融术(MEA)是一种治疗月经过多的微创治疗方法。然而,在用MEA治疗的子宫肌瘤复发后,通常需要额外的治疗。此外,由于这种治疗会消融子宫内膜,因此不适合计划怀孕的患者。为了克服这些问题,我们设计了一种超声引导下微波消融子宫肌瘤供血血管的方法。我们报告了三名使用我们的新方法成功治疗子宫肌瘤继发月经过多的患者。
所有患者术后病程良好,4小时内出院,无并发症发生。此外,术后未发现月经过多复发。我们的方法还减小了肌瘤的最大直径。
这种方法不会消融子宫内膜,表明其在计划怀孕的患者中具有潜在的应用价值。